Clinical Trials on Myeloproliferative Neoplasms (MPN)
Total 107953 results
-
PharmaEssentiaActive, not recruiting
-
Novartis PharmaceuticalsAvailable
-
AOP Orphan Pharmaceuticals AGPharmaEssentia Corporation (for the U.S.)CompletedPolycythemia VeraSpain, Austria, Bulgaria, France, Germany, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine, Czechia
-
Kartos Therapeutics, Inc.UnknownPolycythemia VeraUnited States, Poland, Spain, Germany, Hungary, France
-
ItalfarmacoCompletedPolycythemia VeraGermany, Poland, United Kingdom, Italy, France
-
Incyte CorporationNovartis PharmaceuticalsCompletedPolycythemia VeraUnited States, Canada, France, Italy, United Kingdom, China, Belgium, Germany, Spain, Turkey, Japan, Australia, Korea, Republic of, Netherlands, Russian Federation, Argentina, Thailand, Hungary
-
Incyte CorporationCompletedPolycythemia VeraUnited States, Belgium, Germany, Spain, Italy, United Kingdom, Ireland
-
AOP Orphan Pharmaceuticals AGPharmaEssentia (Co-Sponsor for USA)CompletedPolycythemia VeraSpain, Belgium, Austria, Italy, Bulgaria, Czech Republic, France, Germany, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
PV-NordCompleted
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumWithdrawnPolycythemia Vera
-
King's College LondonCompletedHealthy Men and WomenUnited Kingdom
-
Health DecisionsEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsUnknownHealthy Men | Male ContraceptionUnited States
-
King's College LondonNaturex-DbsCompletedHealthy Men and WomenUnited Kingdom
-
Lundquist Institute for Biomedical Innovation at...National Institutes of Health (NIH); University of WashingtonCompletedHealthy Men | Male ContraceptionUnited States
-
AmgenCompleted
-
H. Lundbeck A/SCompletedHealthy Men and WomenUnited Kingdom
-
National Institutes of Health Clinical Center (CC)CompletedPolycythemia Vera | Chronic Myeloproliferative Disorders | Essential Thrombocytosis | Idiopathic Myelofibrosis | NeutrophilsUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Novartis PharmaceuticalsCompleted
-
Protagonist Therapeutics, Inc.Enrolling by invitationPolycythemia VeraUnited States
-
Hoffmann-La RocheTerminatedPolycythemia VeraUnited States, Canada, Italy, Australia
-
Novartis PharmaceuticalsCompletedPolycythemia VeraHungary, Italy, Belgium, Germany, Spain, Korea, Republic of, Israel, Canada, Turkey, France, Australia, India
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
AOP Orphan Pharmaceuticals AGCompletedPolycythemia VeraAustria
-
AOP Orphan Pharmaceuticals AGPharmaEssentia Corporation (Co-Sponsor for USA)CompletedPolycythemia VeraAustria, Bulgaria, Czech Republic, France, Hungary, Poland, Slovakia, Ukraine
-
California Cancer ConsortiumNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Alaunos TherapeuticsCompletedLymphoma | Multiple Myeloma | Acute Leukemia | Chronic Myeloproliferative Disease | Chronic Lymphoproliferative Disease | Poor-risk Myelodysplasia (MDS)United States
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic-Myeloproliferative Diseases | Neuroblastoma | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Therapy-related ToxicityUnited States
-
Fox Chase Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Essential Thrombocytosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Hodgkin Lymphoma | Myelofibrosis | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Hematopoietic and Lymphoid System Neoplasm | Myeloproliferative Neoplasm | Chronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States
-
Cellenkos, Inc.Recruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruiting
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
French Innovative Leukemia OrganisationCompleted
-
PharmaMarCompletedMyelofibrosisUnited States, Italy
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of Alabama at BirminghamRecruitingExposure to Man-made Visible LightUnited States
-
AGUNCO Obstetrics and Gynecology CentreCompletedLow Serum Testosterone Levels in ManItaly
-
Heinrich-Heine University, DuesseldorfCompleted
-
University of the French West Indies and French...CompletedHealthy and Physically Active Young MenFrance
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID); Palo Alto Medical...CompletedHealthy Men Age 50 Who Are Considering PSA ScreeningUnited States
-
Actuate Therapeutics Inc.Completed
-
Ascentage Pharma Group Inc.WithdrawnMyelofibrosisUnited States
-
Synta Pharmaceuticals Corp.CompletedMyeloproliferative Disorders | AML | MDS | CMLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Hodgkin Lymphoma | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterBellicum PharmaceuticalsTerminatedLeukemia | Myeloma | Myeloproliferative DiseasesUnited States
-
University Hospital, BrestRecruitingPolycythemia Vera | Essential Thrombocythemia | High-risk Patients | Prefibrotic/Early Primary Myelofibrosis | JAK2 V617FFrance
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Fanconi Anemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease | Diamond-blackfan AnemiaUnited States